We are pleased to announce that Paul Roberts will be our next “Visiting Researcher” for the „limits2vision“ programme. During his visit to the Institute for Ophthalmic Research in Tübingen on … read m...

The Foundation Laboratory made a remarkable impact at ARVO 2026, showcasing innovative research, fostering international collaborations, and contributing to key discussions shaping the future of visio...

The active representation of the Institute for Ophthalmic Research in Tübingen, represents the strategic focus on retina physiology and disease mechanisms, as well as its commitment to training the ne...

Julian Wolf’s research integrates multi-omics technologies and computational modeling to unravel the molecular complexity of the human eye and advance the understanding and treatment of retinal diseas...

International Interdisciplinary Symposium - 8.-9. May, 2026 in Tübingen, Germany

Congratulations to Angela Armento and Pietro De Angeli, who have each received prestigious prizes from the Deutsche Ophthalmologische Gesellschaft (DOG) for their groundbreaking research in retinal bi...

This award highlights Simon’s outstanding contributions to complement research

We are excited to announce that up to 20 PhD student positions (funded for up to 3.5 years) will be available in Tübingen and Paris, starting on January 1, 2026.

The binational graduate program “Limits2Vision” explores how energy metabolism operates in the healthy retina and how it is altered in retinal diseases.

Europe’s largest online portal for ophthalmology "Eyefox", interviewed Prof. Marius Ueffing, director of the Institute for Ophthalmic Research Tübingen

Award-winning vision science: Bridging neurotech and ophthalmology at ISCEV 2025

by Daniele Dell´Orco

This study is part of the larger interdisciplinary project "Maintaining Sharp Vision Even in Old Age"

Short summary of 10 key lines of discovery in myopia research, as considered by the authors, and prepared on request by the chair of the International Myopia Conference (IMC) 2024, Professor Weizhong ...

Recording the eye’s intent to focus: This innovation could one day help millions regain near vision lost to aging.

Strong Presence from the Institute for Ophthalmic Research, Tübingen

This meeting marked the first of its kind between the two institutions.

Scientists and clinicians from the Center of Ophthalmology in Tübingen together with colleagues from the Department of Oncology tried a EDCas9, which emerges as a flexible and powerful editing approac...

by Simon Binder

Age-related macular degeneration (AMD) is one of the main causes of blindness in the elderly population and is caused by a combination of risk factors.

Einstellungen wie der Dark Mode oder auch Blaufilter sollen unsere Augen entlasten. Was sagt die aktuelle Studienlage dazu – und was nicht?

A group of scientists from IOR in Tübingen together with colleagues from Heidelberg University, and University College London has systematically investigated 23 genetic mutations in the IFT140 gene.

Kurzsichtigkeit nimmt stark zu. Über die physiologischen Gründe hierfür und mögliche Behandlungsoptionen berichtete Professor Dr. Frank...

A collaborative Study between the "Applied Vision Research" Lab at the Institute for Ophthalmic Research, University of Tübingen, and Bosch Sensortec GmbH

by Patricia Boya

Nitric oxide is a type-selective neuromodulator affecting the temporal, but not the spatial response kinetics of a specific subset of mouse retinal ganglion cells.

Dr Katrin Franke joins the IOR in January 2025 to establish a new research group "Neural Computation in Vision"

Mouse photoreceptors establish a dorsal-ventral chromatic gradient that is attenuated at the retinal output. Korympidou et al. explore how dendrites of inhibitory amacrine cells in the mouse retina re...